Evidence map›Paper›PMID 37373446›Full record

ReviewInternational journal of molecular sciences2023

The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.

Anna Surówka, Piotr Prowans, Michał Żołnierczuk, Marek Miśkiewicz, Tomasz Wawrowski, Marika Skodda, Marta Markowska, Karolina Kędzierska-Kapuza

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anna SurówkaDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.ORCID 0000-0002-8693-9259
Piotr ProwansDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Michał ŻołnierczukDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Marek MiśkiewiczDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.ORCID 0000-0002-3691-343X
Tomasz WawrowskiDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Marika SkoddaDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Marta MarkowskaDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, Poland.
Karolina Kędzierska-KapuzaDepartment of Gastroenterological Surgery and Transplantology, National Medical Institute of the Ministry of Interior Affairs and Administration, 02-507 Warsaw, Poland.
Pomeranian Medical University · PLMinistry of Interior and Administration · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review focuses on the role of metalloproteinases in the pathogenesis of myocardial injury in various disease entities. It reveals how the expression and serum levels of metalloproteinases and their inhibitors change in many disease states. At the same time, the study offers a review of the impact of immunosuppressive treatment on this relationship. Modern immunosuppressive treatment is based mainly on the use of calcineurin inhibitors, including cyclosporine A and tacrolimus. The use of these drugs may carry a number of side effects, specifically to the cardiovascular system. The scale and degree of long-term influence on the organism remains unclear, but a significant risk of complications for transplant recipients who take immunosuppressive drugs as part of their daily treatment is to be expected. Therefore, the knowledge on this subject should be expanded and the negative effects of post-transplant therapy minimized. Immunosuppressive therapy plays an important role in the expression and activation of tissue metalloproteinases and their specific inhibitors, which leads to many tissue changes. The presented study is a collection of research results on the effects of calcineurin inhibitors on the heart, with particular emphasis placed on the participation of MMP-2 and MMP-9. It is also an analysis of the effects of specific heart diseases on myocardial remodeling through inductive or inhibitory effects on matrix metalloproteinases and their inhibitors.

Indexed as

Calcineurin InhibitorsImmunosuppressive AgentsCalcineurinCyclosporineMatrix MetalloproteinasesTacrolimusCalcineurinCalcineurin InhibitorsCyclosporineImmunosuppressive AgentsMatrix MetalloproteinasesTacrolimuscalcineurin inhibitorscyclosporine Ametalloproteinasestacrolimus

Identifiers

PMID37373446
PMCPMC10299316
OpenAlexW4381149280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.